AMAG Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own AMAG Pharmaceuticals Inc.
SPDR S&P Biotech ETF
1,755,101
5.09%
4,515
0.73%
09/06/2018
iShares Core S&P Small Cap ETF
1,638,403
4.75%
0
0.08%
09/06/2018
Fidelity VIP - Mid Cap Portfolio
1,089,300
3.16%
0
0.3%
07/31/2018
Vanguard Small Cap Index Fund
817,627
2.37%
9,115
0.02%
07/31/2018
Vanguard Total Stock Market Index Fund
816,814
2.37%
0
0%
07/31/2018
Government Pension Fund - Global (The)
739,665
2.15%
167,426
0%
12/31/2017
iShares Russell 2000 ETF
715,211
2.08%
-381
0.04%
09/06/2018
iShares S&P Small Cap 600 Value ETF
549,770
1.6%
672
0.19%
09/06/2018
DFA US Small Cap Value Portfolio
497,564
1.44%
0
0.06%
04/30/2018
Vanguard Small Cap Growth Index Fund
466,701
1.35%
5,832
0.04%
07/31/2018
| Address |
1100 Winter Street
Waltham Massachusetts 02451
United States
|
|
Employees
|
- |
| Website |
http://www.amagpharma.com |
| Updated |
07/08/2019 |
| AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the research, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. |
